Cue Biopharma WT1-targeted immunotherapy

· Cue Biopharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cue Biopharma WT1-targeted immunotherapy, covering 2026-01-22 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers [Phase 1]